Functional Assessment of Vascular Reactivity in Small Vessel Disease and Alzheimer's disease (FAVR-II Study).
Summary
This study seeks to understand the relationship between brain blood flow and the memory symptoms seen in normal aging, mild cognitive impairment, Alzheimer's disease, and a blood vessel condition called cerebral amyloid angiopathy.
Eligibility
Eligible ages: 60 to 90
Accepts healthy participants: Yes
Inclusion criteria:
You may be eligible if you have concerns about your memory, have no concerns but are interested in participating in study on brain health, or if a doctor has told you that you have Alzheimer's disease or cerebral amyloid angiopathy.
Exclusion criteria:
You will not be able to participate if you live in a nursing home, cannot read and write in English, or have been diagnosed with other neurological diseases such as a stroke, brain tumour, or multiple sclerosis.
Participate
Additional information
Contact information
Please contact Jennifer Cameron at Jennifer.Cameron3@albertahealthservices.ca or call 403-944-1594.
Principal investigator:
Eric Smith
Clinical trial:
No
REB-ID:
REB15-0601
External links